Truist Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481M Buy
400,653
+31,132
+8% +$31.8M 0.57% 40
2026
Q1
$340M Buy
369,521
+2,754
+0.8% +$2.79M 0.46% 46
2025
Q4
$394M Buy
366,767
+9,384
+3% +$8.97M 0.53% 40
2025
Q3
$273M Sell
357,383
-19,695
-5% -$14.7M 0.37% 50
2025
Q2
$294M Buy
377,078
+5,075
+1% +$3.94M 0.43% 44
2025
Q1
$307M Buy
372,003
+5,217
+1% +$4.34M 0.49% 37
2024
Q4
$283M Buy
366,786
+7,112
+2% +$5.89M 0.44% 42
2024
Q3
$319M Buy
359,674
+8,006
+2% +$7.2M 0.5% 39
2024
Q2
$318M Buy
351,668
+38,090
+12% +$30.5M 0.48% 38
2024
Q1
$244M Buy
313,578
+41,545
+15% +$29.6M 0.37% 52
2023
Q4
$159M Sell
272,033
-35,553
-12% -$20.8M 0.25% 90
2023
Q3
$165M Buy
307,586
+75,195
+32% +$38.7M 0.28% 82
2023
Q2
$109M Sell
232,391
-11,010
-5% -$4.62M 0.18% 124
2023
Q1
$83.6M Sell
243,401
-724
-0.3% -$244K 0.14% 143
2022
Q4
$89.3M Buy
244,125
+9,367
+4% +$3.32M 0.16% 139
2022
Q3
$75.9M Sell
234,758
-2,575
-1% -$816K 0.15% 141
2022
Q2
$77M Sell
237,333
-20,616
-8% -$6.19M 0.14% 146
2022
Q1
$73.9M Sell
257,949
-5,466
-2% -$1.41M 0.12% 179
2021
Q4
$72.8M Buy
263,415
+6,259
+2% +$1.59M 0.11% 183
2021
Q3
$59.4M Buy
257,156
+5,258
+2% +$1.3M 0.1% 208
2021
Q2
$57.8M Sell
251,898
-7,455
-3% -$1.5M 0.09% 218
2021
Q1
$48.5M Buy
259,353
+4,384
+2% +$858K 0.08% 239
2020
Q4
$43M Sell
254,969
-10,698
-4% -$1.6M 0.08% 234
2020
Q3
$39.3M Sell
265,667
-53,020
-17% -$8.21M 0.09% 225
2020
Q2
$52.3M Buy
318,687
+11,000
+4% +$1.69M 0.12% 186
2020
Q1
$42.7M Buy
307,687
+19,596
+7% +$2.69M 0.11% 195
2019
Q4
$37.9M Buy
288,091
+257,844
+852% +$29.9M 0.08% 256
2019
Q3
$3.38M Buy
30,247
+110
+0.4% +$12.2K 0.06% 279
2019
Q2
$3.34M Buy
30,137
+18
+0.1% +$2.12K 0.06% 277
2019
Q1
$3.91M Sell
30,119
-115
-0.4% -$14K 0.07% 254
2018
Q4
$3.5M Buy
30,234
+487
+2% +$54.4K 0.07% 252
2018
Q3
$3.19M Buy
29,747
+1,629
+6% +$163K 0.06% 295
2018
Q2
$2.4M Sell
28,118
-1,238
-4% -$102K 0.05% 331
2018
Q1
$2.27M Sell
29,356
-588
-2% -$47.3K 0.04% 342
2017
Q4
$2.53M Sell
29,944
-749
-2% -$63.7K 0.05% 327
2017
Q3
$2.63M Sell
30,693
-491
-2% -$40.3K 0.05% 323
2017
Q2
$2.57M Sell
31,184
-2,392
-7% -$195K 0.05% 328
2017
Q1
$2.82M Sell
33,576
-3,511
-9% -$281K 0.06% 321
2016
Q4
$2.73M Sell
37,087
-1,602
-4% -$119K 0.06% 322
2016
Q3
$3.1M Buy
38,689
+2,784
+8% +$223K 0.06% 311
2016
Q2
$2.83M Sell
35,905
-972
-3% -$73.2K 0.06% 320
2016
Q1
$2.66M Buy
36,877
+2,883
+8% +$218K 0.07% 283
2015
Q4
$2.87M Buy
33,994
+420
+1% +$34.9K 0.07% 269
2015
Q3
$2.81M Buy
33,574
+144
+0.4% +$12.2K 0.07% 272
2015
Q2
$2.79M Sell
33,430
-2,302
-6% -$175K 0.08% 257
2015
Q1
$2.6M Sell
35,732
-7,153
-17% -$509K 0.07% 255
2014
Q4
$2.96M Sell
42,885
-3,006
-7% -$203K 0.09% 231
2014
Q3
$2.98M Sell
45,891
-7,794
-15% -$493K 0.09% 228
2014
Q2
$3.34M Sell
53,685
-772
-1% -$46.1K 0.1% 226
2014
Q1
$3.21M Sell
54,457
-2,979
-5% -$166K 0.1% 223
2013
Q4
$2.93M Sell
57,436
-1,143
-2% -$57.2K 0.09% 224
2013
Q3
$2.95M Sell
58,579
-12,826
-18% -$671K 0.1% 215
2013
Q2
$3.51M Buy
+71,405
New +$3.89M 0.13% 189

Other funds holding LLY

Truist Financial's LLY Position: Q2 2026 in Review

Truist Financial increased its Eli Lilly (LLY) stake by 8.4% in Q2 2026, buying an estimated $31.8M and bringing the position to 400,653 shares worth $481M. The position accounts for 0.57% of the portfolio, ranked #40.

Truist Financial first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Truist Financial held 400,653 shares of Eli Lilly worth $481M as of Q2 2026.
  • Truist Financial bought 31,132 Eli Lilly shares in Q2 2026, an estimated $31.8M.
  • Eli Lilly made up 0.57% of Truist Financial's portfolio in Q2 2026, its #40 holding.
  • Truist Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.